Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Curr Top Med Chem ; 19(11): 931-943, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31109276

RESUMO

BACKGROUND: In the last decade, the harmful use of dioxin has been demonstrated in human health and in the whole environment. It is well known among scientists that 2, 3, 7, 8-tetrachloro dibenzo-p-dioxin (TCDD) is an environmental pollutant that causes endocrine disruption, which causes male reproductive toxicity. OBJECTIVE: The objective of the present study was to evaluate the toxicity effect of low doses of TCDD in male CD1 mice. MATERIALS AND METHODS: Three concentrations of TCDD (0.375, 0.75, 1.5 mg / kg) were analyzed and the effects on spermatozoa were evaluated 10 days after oral administration of the product. As bioindicators of TCDD toxicity, an exhaustive analysis of several spermatic parameters including motility, vitality, count, morphology and viability, flow cytometry was used to determine the affected sperm population by cytotoxicity and apoptosis. In addition, a morphometric analysis of testicles was performed. RESULTS: The results show that the body weight of the treated animals was reduced in medium and high doses (0.75, 1.5 mg / kg) with respect to the control groups. In the groups treated with TCDD, the abnormal head of the sperm increased by 52.5% more than the control group. Significant differences in apoptosis were observed between the negative control and vehicle control, including the median dose (0.75 mg / kg). CONCLUSION: It is concluded that at these low doses there was an impact on the quality of the mouse sperm, adding an effect on apoptosis and cytotoxicity of sperm exposed to these doses of TCDD.


Assuntos
Dibenzodioxinas Policloradas/toxicidade , Espermatozoides/efeitos dos fármacos , Administração Oral , Animais , Apoptose/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Relação Dose-Resposta a Droga , Masculino , Camundongos , Dibenzodioxinas Policloradas/administração & dosagem , Espermatozoides/patologia , Relação Estrutura-Atividade
2.
Curr Pharm Des ; 22(33): 5079-5084, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27494067

RESUMO

BACKGROUND: The emergence of reduced susceptibility to fluoroquinolones among Salmonella enterica serotype Typhimurium isolates leading to clinical failure of treatment poses a great therapeutic challenge. METHODS: The current study is focused on the evaluation of the minimum inhibitory concentration (MIC) of quinolones in 29 Salmonella typhimurium of 86 Salmonella spp. strains, obtained from pigs from the State of Mexico. The MIC was performed with the Kirby-Bauer method. On the other hand, the GyrA gene was sequenced. The present study was undertaken to describe the resistance profiles and fluoroquinolone resistance mechanism of Salmonella Typhimurium. RESULTS: The DNA sequence of the gyrA genes from Salmonella enterica serovar typhimurium revealed strong similarity between gyrA and its counterpart in Escherichia coli. The sequencing of quinolone resistance-determining region (QRDR) of the gyrA gene showed the presence of mutation at either S83 or at D87 in almost all the Salmonella typhimurium isolates. CONCLUSION: This mutation, although phenotypically expressed as decreased susceptibility to fluoroquinolones goes undetected by the disk diffusion method using the present method of Kirby-Bauer. Hence, it can increase morbidity and mortality due to delay in appropriate antibiotic treatment.


Assuntos
Antibacterianos/farmacologia , DNA Girase/genética , Farmacorresistência Bacteriana/efeitos dos fármacos , Mutação , Quinolonas/farmacologia , Salmonella typhimurium/efeitos dos fármacos , Animais , Antibacterianos/química , Testes de Sensibilidade Microbiana , Reação em Cadeia da Polimerase , Quinolonas/química , Análise de Sequência de DNA , Suínos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...